Consensus Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Market Closed - Nyse Other stock markets 01:45:00 11/05/2024 am IST			5-day change	1st Jan Change
279.9 ^USD	0.00%		0.00%	-12.71%

08/05	UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating	MT
08/05	RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420	MT

Evolution of the average Target Price on Bio-Rad Laboratories, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c227afdca903.y2mW9cOsWg6kA3AfvhXZVl3lSoDvkio4iRi9-VzJCoA.mRreu4b-NHj0Zzd27izrGzLWO7i1o1BZ8DXXlAiLaLW7EdGAlcRrfOxtIQ~e1362f97c77e75a4348144c74c77042d

Analyst Recommendations on Bio-Rad Laboratories, Inc.

UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating	08/05	MT
RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420	08/05	MT
Citigroup Adjusts Price Target on Bio-Rad Laboratories to $300 From $365	08/05	MT
RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474	29/04	MT
Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322	15/04	MT
RBC Trims Price Target on Bio-Rad Laboratories to $474 From $480, Keeps Outperform Rating	08/04	MT
Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $365 From $400	03/04	MT
UBS Adjusts Bio-Rad Laboratories Price Target to $420 From $395, Maintains Buy Rating	16/02	MT
RBC Trims Price Target on Bio-Rad Laboratories to $480 From $484, Keeps Outperform Rating	16/02	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	03/01
UBS Initiates Coverage on Bio-Rad Laboratories With Buy Rating, $395 Price Target	07/12	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $482 From $513, Notes 'Near-Term Headwinds,' Keeps Outperform Rating	27/23/27	MT
ANALYST RECOMMENDATIONS : Amazon, Comcast, Intel, Merck, Roblox...	27/23/27
Wells Fargo Adjusts Price Target on Bio-Rad Laboratories to $525 From $550, Keeps Overweight Rating	07/23/07	MT
Wells Fargo Lowers Price Target on Bio-Rad Laboratories to $525 From $550, Maintains Overweight Rating	07/23/07	MT
Credit Suisse Adjusts Bio-Rad Laboratories' Price Target to $550 From $580, Keeps Outperform Rating	04/23/04	MT
RBC Raises Price Target on Bio-Rad Laboratories to $524 From $522, Maintains Outperform Rating	04/23/04	MT
RBC Cuts Bio-Rad Laboratories' Price Target to $522 From $536, Keeps Outperform Rating	17/23/17	MT
Wells Fargo Initiates Bio-Rad Laboratories With Overweight Rating, $550 Price Target	16/23/16	MT
ANALYST RECOMMENDATIONS : Adobe, Wells Fargo, American Express...	16/23/16
RBC Boosts Price Target on Bio-Rad Laboratories to $536 From $531, Maintains Outperform Rating	15/23/15	MT
Citigroup Adjusts Bio-Rad Laboratories' Price Target to $525 From $550, Keeps Buy Rating	08/23/08	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $531 From $582 After Guidance Cut But Sees Buying Opportunity After Stock Drop; Outperform Kept	08/23/08	MT
Credit Suisse Cuts Bio-Rad Laboratories' PT to $580 From $680 After Lower-Than-Expected Q1 Results, Keeps Outperform Rating	05/23/05	MT
RBC Boosts Price Target on Bio-Rad Laboratories to $582 From $579, Maintains Outperform Rating	14/23/14	MT